Amgen Inc. (AMGN)

Income Statement
Quarterly Data

Difficulty: Beginner

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Amgen Inc., Consolidated Income Statement (quarterly data)

USD $ in millions

	3 months ended	Jun 30, 2019		Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Product sales
	Cost of sales
	Gross profit from product sales
	Other revenues
	Research and development
	Selling, general and administrative
	Other
	Operating income
	Interest expense, net
	Interest and other income, net
	Income before income taxes
	Provision for income taxes
	Net income

Item	Description	The company
Product sales	Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.	Amgen Inc.’s product sales declined from Q4 2018 to Q1 2019 but then slightly increased from Q1 2019 to Q2 2019.
Operating income	The net result for the period of deducting operating expenses from operating revenues.	Amgen Inc.’s operating income increased from Q4 2018 to Q1 2019 and from Q1 2019 to Q2 2019.
Income before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Amgen Inc.’s income before income taxes increased from Q4 2018 to Q1 2019 and from Q1 2019 to Q2 2019.
Net income	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Amgen Inc.’s net income increased from Q4 2018 to Q1 2019 and from Q1 2019 to Q2 2019.

	Amgen Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Amgen Inc. (AMGN)

Income StatementQuarterly Data

Income Statement
Quarterly Data